Alx Oncology Holdings Inc

NASDAQ:ALXO   12:59:59 PM EDT
33.52
-2.80 (-7.71%)
Earnings Announcements

Alx Oncology Posts Q3 Loss Per Share Of $0.61

Published: 11/11/2021 22:13 GMT
Alx Oncology Holdings Inc (ALXO) - Alx Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights.
Q3 GAAP Loss per Share $0.61.
Q3 Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.